# Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury

> **NCT06282965** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Arizona** · enrollment: 90 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Angiotensin (1-7)
- **DRUG:** Sterile saline

## Key facts

- **NCT ID:** NCT06282965
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282965, "Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06282965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*